We investigated the differential importance of MTH1 in normal and cancer cells and found that MA−24 outperformed conventional chemotherapeutic drugs in indiscriminately attacking both cancer and normal cells by specifically targeting cancer cells to exert its anticancer effects. Here, NUDT1 is linked to cancer.